Biometrics · 1993 · 25 citations · 20 references
PharmacyBiostatisticsToxicologyCancer EpidemiologyDose-response ModelingSurvival AnalysisCancer Survival AnalysisDose-response AssessmentExposure-response AnalysisSurvival ModelingTumor Growth KineticsTumorigenicity AssessmentCancer Dose-response AssessmentCancer Risk EstimationDose-response Model BuildingDose-response Relationships In CancerDose-response Tumorigenicity TestingTumor Response EvaluationTumor Response PredictionWeibull Model
In this paper, a new method of estimating tumorigenic potency is proposed that takes into account information on survival and, when available, the underlying cause of death. Specifically, Weibull distributions are used to describe the time to tumor occurrence (X), the time to death as a result of tumor occurrence (Y), and the time of death from causes other than tumor occurrence (Z). The distributions of X and Y are related via a lethality parameter p lying between 0 (incidental tumors) and 1 (rapidly fatal tumors). The index of tumorigenic potency is defined as the dose inducing a specified excess tumor response rate (in the range of 25%-50%) following exposure for an extended period encompassing most of the expected lifespan. Application of the proposed method is illustrated using several data sets taken from the literature.
20
Department of Health, Education, and Welfare
Theodore Cooper · Military Medicine · 1976 · 4K citations · Full text
Ranking Possible Carcinogenic Hazards
Bruce N. Ames, Renae Magaw, Lois Swirsky Gold · Science · 1987 · 564 citations
Effects of dose and time in a long-term, low-dose carcinogenic study.
Littlefield Na, Farmer Jh, Gaylor Dw et al. · PubMed · 1980 · 135 citations
Pharmacy, Pharmacology, Toxicology +16